MedTrace Logo

Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth

NCT00624572 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-02-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.

Conditions

  • Dental Pulp Necrosis

Interventions

DRUG

chlorexidine

Chlorexidine gel 1% during 7 days inside root canals

Sponsors & Collaborators

  • Universidade Federal do Ceara

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-11-30
Completion
2009-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00624572 on ClinicalTrials.gov